| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VXRT | Common Stock | Options Exercise | $5,654 | +18,240 | $0.3100 | 18,240 | 11 Jun 2021 | Direct | ||
| transaction | VXRT | Common Stock | Sale | $86,109 | -10,000 | -55% | $8.61* | 8,240 | 11 Jun 2021 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VXRT | Stock Option (right to buy) | Options Exercise | $0 | -18,240 | -33% | $0.000000 | 36,480 | 11 Jun 2021 | Common stock | 18,240 | $0.3100 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The shares subject to this option shall vest annually over three years from the vesting commencement date of October 25, 2019, the date of the grantee's appointment as a director of Vaxart, Inc. |